posted on
Dec 31, 2011 12:04PM
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: T3
Or Leckrone is in absolute control and we negotiated nothing with our Leckrone settlement. I would hope management would give long term shareholders an indication that great things will happen if we get a favorable T3 outcome. It is the least they could do. Otherwise make it clear we are going no where and SPs of the past will not happen again. Please let us know the endgame.
GLTAL
1 Recommendations
Loading...
Loading...
1
Jan 02, 2012 11:58AM
1
Jan 02, 2012 09:59PM
New Message
Please
login
to post a reply